JAMA 子刊|母乳喂养时间与儿童癌症风险降低有关
该研究获取了超过30万名儿童纯母乳喂养持续时间的信息。Signe Holst Søegaard博士团队基于丹麦国家儿童健康登记处(DNCHR)的行政记录开展了一项基于登记的队列研究,调查了2005年至2018年期间丹麦出生儿童的纯母乳喂养持续时间与儿童风险直接的关系。
撰文
责编
制作
排版 | Sheila 校对 | uu
*本文由深圳市拾玉儿童公益基金会“儿童肿瘤前沿”团队编译或约稿,文中图表均源引自文献原文。本文著作权归文章作者所有,欢迎个人转发分享,未经允许禁止转载,作者拥有所有法定权利,违者必究。如需转载,请留言或联系[email protected]。本文旨在分享儿童肿瘤科研前沿成果,不是治疗方案推荐。如需获得疾病治疗方案指导,请前往正规医院就诊。
▼滑动查看更多▼
原文摘要(Abstract)
Importance: Breastfeeding has been suggested to protect against childhood cancers, particularly acute lymphoblastic leukemia (ALL). However, the evidence stems from case-control studies alone.
Objective: To investigate whether longer duration of exclusive breastfeeding is associated with decreased risk of childhood ALL and other childhood cancers.
Design, setting, and participants: This population-based cohort study used administrative data on exclusive breastfeeding duration from the Danish National Child Health Register. All children born in Denmark between January 2005 and December 2018 with available information on duration of exclusive breastfeeding were included. Children were followed up from age 1 year until childhood cancer diagnosis, loss to follow-up or emigration, death, age 15 years, or December 31, 2020. Data were analyzed from March to October 2023.
Exposure: Duration of exclusive breastfeeding in infancy.
Main outcomes and measures: Associations between duration of exclusive breastfeeding and risk of childhood cancer overall and by subtypes were estimated as adjusted hazard ratios (AHRs) with 95% CIs using stratified Cox proportional hazards regression models.
Results: A total of 309 473 children were included (51.3% boys). During 1 679 635 person-years of follow-up, 332 children (0.1%) were diagnosed with cancer at ages 1 to 14 years (mean [SD] age at diagnosis, 4.24 [2.67] years; 194 boys [58.4%]). Of these, 124 (37.3%) were diagnosed with hematologic cancers (81 [65.3%] were ALL, 74 [91.4%] of which were B-cell precursor [BCP] ALL), 44 (13.3%) with central nervous system tumors, 80 (24.1%) with solid tumors, and 84 (25.3%) with other and unspecified malignant neoplasms. Compared with exclusive breastfeeding duration of less than 3 months, exclusive breastfeeding for 3 months or longer was associated with a decreased risk of hematologic cancers (AHR, 0.66; 95% CI, 0.46-0.95), which was largely attributable to decreased risk of BCP-ALL (AHR, 0.62; 95% CI, 0.39-0.99), but not with risk of central nervous system tumors (AHR, 0.96; 95% CI, 0.51-1.88) or solid tumors (AHR, 0.87; 95% CI, 0.55-1.41).
Conclusions and relevance: In this cohort study, longer duration of exclusive breastfeeding was associated with reduced risk of childhood BCP-ALL, corroborating results of previous case-control investigations in this field. To inform future preemptive interventions, continued research should focus on the potential biologic mechanisms underlying the observed association.
DOI: 10.1001/jamanetworkopen.2024.3115